ATE464063T1 - Topisch applizierbare kosmetische oder pharmazeutische zusammensetzung zur prävention oder behandlung androgener alopezie - Google Patents

Topisch applizierbare kosmetische oder pharmazeutische zusammensetzung zur prävention oder behandlung androgener alopezie

Info

Publication number
ATE464063T1
ATE464063T1 AT04425028T AT04425028T ATE464063T1 AT E464063 T1 ATE464063 T1 AT E464063T1 AT 04425028 T AT04425028 T AT 04425028T AT 04425028 T AT04425028 T AT 04425028T AT E464063 T1 ATE464063 T1 AT E464063T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
prevention
treatment
androgenic alopecia
topically applicable
Prior art date
Application number
AT04425028T
Other languages
English (en)
Inventor
Ugo Raffaello Citernesi
Original Assignee
Farmaka Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaka Srl filed Critical Farmaka Srl
Application granted granted Critical
Publication of ATE464063T1 publication Critical patent/ATE464063T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT04425028T 2003-02-28 2004-01-20 Topisch applizierbare kosmetische oder pharmazeutische zusammensetzung zur prävention oder behandlung androgener alopezie ATE464063T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000369A ITMI20030369A1 (it) 2003-02-28 2003-02-28 Composizione cosmetica o farmaceutica ad uso topico per impedire o contrastare l'alopecia androgenetica.

Publications (1)

Publication Number Publication Date
ATE464063T1 true ATE464063T1 (de) 2010-04-15

Family

ID=32800694

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04425028T ATE464063T1 (de) 2003-02-28 2004-01-20 Topisch applizierbare kosmetische oder pharmazeutische zusammensetzung zur prävention oder behandlung androgener alopezie

Country Status (6)

Country Link
US (1) US6953571B2 (de)
EP (1) EP1454633B1 (de)
AT (1) ATE464063T1 (de)
DE (1) DE602004026499D1 (de)
ES (1) ES2341855T3 (de)
IT (1) ITMI20030369A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849481A4 (de) * 2005-01-07 2012-11-28 Rohto Pharma Zusammensetzung zur topischen anwendung
US20170266218A1 (en) * 2016-03-21 2017-09-21 Steve McNerlin Nad+ coenzyme formulation and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
JPS6212721A (ja) 1985-07-10 1987-01-21 Yasahiro Morita 椎茸霊芝の製造法
AU5856090A (en) * 1989-07-07 1991-02-06 Endorecherche Inc. Androgen derivatives for use in the inhibition of sex steroid activity
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
FR2732597B1 (fr) * 1995-04-05 1997-05-16 Oreal Utilisation dans une composition en tant qu'activateur et/ou stabilisateur de cyclooxygenase d'au moins un derive de pyrimidine substitue en 6
IT1318379B1 (it) * 2000-03-08 2003-08-25 Ira Srl Composizione cosmetica o farmaceutica utile per inibire o ritardarel'alopecia umana mediante applicazione topica della composizione.

Also Published As

Publication number Publication date
ITMI20030369A1 (it) 2004-09-01
US20040197887A1 (en) 2004-10-07
US6953571B2 (en) 2005-10-11
EP1454633A1 (de) 2004-09-08
ES2341855T3 (es) 2010-06-29
DE602004026499D1 (de) 2010-05-27
EP1454633B1 (de) 2010-04-14

Similar Documents

Publication Publication Date Title
TR200000576T1 (tr) Lipozomal kapsüllenmiş taksan uygulanması için bir yöntem
ATE214609T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leberkrankheiten
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
GB0223038D0 (en) Therapeutic compounds
EP1765388B8 (de) Kombinationstherapie zur vorbeugung oder behandlung der alzheimerschen erkrankung sowie set hierfür
EE05556B1 (et) 3-hüdroksü-3-metüülglutarüüli koensüümi kasutamine reduktaasi inhibiitorina ravimi valmistamiseks diabeetilise neuropaatia raviks
GB0420888D0 (en) Compounds and uses
DE60112055D1 (de) Inhibitoren von gamma-secretase
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
MY138883A (en) Use of asiatic acid for treatment of cencer
AU2003295773A8 (en) Treatment of liver disease with active vitamin d compounds
ATE401875T1 (de) Pharmazeutische feste dispersionen von modafinil- verbindungen
AU2003212634A1 (en) Compounds useful in the treatment of cancer
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
AU2001262401A1 (en) Use of ellagic acid as anti-pollution cosmetic agent
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
EP1512405A4 (de) Zusammensetzung zur linderung von chloasma und zusammensetzung zur linderung von stumpfem aussehen
SG153661A1 (en) Formulation and methods for the treatment of thrombocythemia
CY1107312T1 (el) Θειικη 3,5,3’-τριιωδοθυρονινη σαν θυρεοειδο-μιμητικος παραγοντας και φαρμακευτικα σκευασματα της
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
ATE464063T1 (de) Topisch applizierbare kosmetische oder pharmazeutische zusammensetzung zur prävention oder behandlung androgener alopezie
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
ATE516040T1 (de) Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis
WO2006058298A3 (en) A method of administering anti-angiogenic agents and a method of treating disease using same
AU2003265107A1 (en) Pharmaceutical composition comprising bando deep ocean water of the concentrate thereof for treatment and prevention of liver disease

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties